HMOX1 and cancer: Additionally, inhibition of the histamine N-methyltransferase/human epidermal growth factor receptor 2 axis enhances sensitivity to cisplatin and reduces cancer stem cell properties by disrupting the Nrf2/HO-1 pathway in H441 cells [70].